Definitive Contract 75N91020C00019
Award Date 9/21/20
Potential Completion Date 9/20/23
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Richmond, CA 94801, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $225,000.00 firm-fixed-price contract to Klesis, LLC, a small business, to conduct research and development on "Enabling Clinical Decision Support for Guideline Based Cancer Symptom Management" under its Small Business Innovation Research (SBIR) program. This contract supports the overall goals of the SBIR program to stimulate innovation, strengthen the role of small businesses...
- This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
- This federal contract award, valued at $395,613.00, was issued by the National Cancer Institute (NCI) to Impact Business Information Solutions, Inc., doing business as Solutions Inc. The contract is a Small Business Innovation Research (SBIR) Phase I award, designated as a total small business set-aside. The contract aims to develop a "Unified Data Commons Solution for Public Domain, In-House and Third-Party Multimodal Clinical Data", which supports advanced data management and...
- This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...
- This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
- This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, part of the National Institutes of Health, to Greenwave LLC, a small disadvantaged business, to develop informatics tools to measure cancer care coordination. The contract has a firm fixed price of $274,441.00 and a completion date of June 17, 2018. As an SBIR Phase I award, this contract is focused on the initial research and development of the proposed solution.</p>